Review



rhoa glisa activation assay  (Cytoskeleton Inc)


Bioz Verified Symbol Cytoskeleton Inc is a verified supplier
Bioz Manufacturer Symbol Cytoskeleton Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cytoskeleton Inc rhoa glisa activation assay
    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a <t>GLISA</t> kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).
    Rhoa Glisa Activation Assay, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 508 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pmc13123509-614-0-6?v=Cytoskeleton+Inc
    Average 96 stars, based on 508 article reviews
    rhoa glisa activation assay - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair"

    Article Title: Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.03.017

    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a GLISA kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).
    Figure Legend Snippet: Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a GLISA kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).

    Techniques Used: Expressing, Western Blot, Membrane



    Similar Products

    96
    Cytoskeleton Inc rhoa glisa activation assay
    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a <t>GLISA</t> kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).
    Rhoa Glisa Activation Assay, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pmc13123509-614-0-6?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    rhoa glisa activation assay - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc rhoa pull down activation assay biochem kit
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Rhoa Pull Down Activation Assay Biochem Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pmc13092739-78-0-10?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    rhoa pull down activation assay biochem kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc bk036
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Bk036, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pmc13092739-78-13-10?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    bk036 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc rho activation assay biochemistry kit
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Rho Activation Assay Biochemistry Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pm42219803-34-1-6?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    rho activation assay biochemistry kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc rhoa g lisa activation assay
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Rhoa G Lisa Activation Assay, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pm42185270-338-20-27?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    rhoa g lisa activation assay - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc rho gtpase pull down assay kit
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Rho Gtpase Pull Down Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pm42155732-83-23-28?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    rho gtpase pull down assay kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    95
    Cytoskeleton Inc rac1 cdc42 activation assay kit
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Rac1 Cdc42 Activation Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pmc13098526-23-0-5?v=Cytoskeleton+Inc
    Average 95 stars, based on 1 article reviews
    rac1 cdc42 activation assay kit - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc activation assay biochem kitstm
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Activation Assay Biochem Kitstm, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/10__3390_slash_cancers18101579-92-11-15?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    activation assay biochem kitstm - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc g lisa rhoa activation assay biochem kit
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    G Lisa Rhoa Activation Assay Biochem Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pm42114608-70-4-19?v=Cytoskeleton+Inc
    Average 96 stars, based on 1 article reviews
    g lisa rhoa activation assay biochem kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    94
    Cytoskeleton Inc rhoa elisa bk150
    Identification of CL16 binding to <t>RhoA</t> by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.
    Rhoa Elisa Bk150, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa/pm42114608-70-13-19?v=Cytoskeleton+Inc
    Average 94 stars, based on 1 article reviews
    rhoa elisa bk150 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    Image Search Results


    Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a GLISA kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).

    Journal: Bioactive Materials

    Article Title: Mechanically sensitized hydrogel microspheres trigger membrane receptor switch for cartilage repair

    doi: 10.1016/j.bioactmat.2026.03.017

    Figure Lengend Snippet: Effect of OBNC microspheres on regulating MSCs. A) The expression of FAK and p-FAK detected by Western blot analysis. B) Quantitative analysis of the Western blot results. C) The expression of the integrin-α5 gene. D) The expression of the integrin-α8 gene. E) The expression of the Lamb-2 gene. F) The expression of the Spp-1 gene. G) The expression of the Vav-3 gene. H) The expression of the CDC-42 gene. I) Detection of the CDC-42 active protein by a GLISA kit. J) Detection of Rac-1 active protein by a GLISA kit. K) Detection of Rho A active protein by a GLISA kit. L) Mechanism of OBNC hydrogels triggering the membrane receptor switch and activating integrin receptors. (ns: non-significant, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001).

    Article Snippet: RhoA GLISA Activation Assay (No. BK124, Cytoskeleton, USA), CDC42 GLISA Activation Assay (No. BK127, Cytoskeleton, USA), and Rac1 GLISA Activation Assay (No. BK128, Cytoskeleton, USA) were used to measure the activation of the GTPase protein family.

    Techniques: Expressing, Western Blot, Membrane

    Identification of CL16 binding to RhoA by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.

    Journal: STAR Protocols

    Article Title: Protocol to identify covalent inhibitors targeting RhoA Cys16

    doi: 10.1016/j.xpro.2026.104494

    Figure Lengend Snippet: Identification of CL16 binding to RhoA by gel-based ABPP experiment (A) Rationale of gel-based ABPP for screening compound binding to RhoA in vitro . Purified RhoA protein was pre-treated with solvent control or library compounds followed by labelling with fluorescent activity-based probes. (B) Expected outcomes in gel-based ABPP. In the 1 st round of screening, compound binding to RhoA results in a decrease in in-gel fluorescence (FL) intensity. Further validation of the binding can be performed by experiments using varying concentrations of the hit compounds. In the 2 nd round of screening, selected hits are examined for their binding to Cdc42 and Rac1 to determine their selectivity for RhoA.

    Article Snippet: RhoA Pull-down Activation Assay Biochem Kit (bead pull-down format) , Cytoskeleton , Cat# BK036.

    Techniques: Binding Assay, In Vitro, Purification, Solvent, Control, Activity Assay, Fluorescence, Biomarker Discovery

    Validation of CL16-RhoA binding by LC-MS/MS experiments (A) Workflow of LC-MS/MS experiments to detect RhoA-CL16 engagement in HCT116 cells. CL16-treated cells were harvested, digested and analyzed by LC-MS/MS. (B) Representative MS/MS showing CL16 modification on RhoA Cys16 in HCT116 cells. (C) Workflow of LC-MS/MS experiments using CL16-alkyne (a CL16-molecular probe) to study target profile of CL16. (D) Volcano plot revealing protein targets of CL16 identified by CL16-molecular probe. Statistical analyses were performed by two-tailed Student’s t-test by MS Excel. (E) Venn diagram summarizing the protein targets of CL16 identified in (A) and (C), highlighting RhoA as the primary target.

    Journal: STAR Protocols

    Article Title: Protocol to identify covalent inhibitors targeting RhoA Cys16

    doi: 10.1016/j.xpro.2026.104494

    Figure Lengend Snippet: Validation of CL16-RhoA binding by LC-MS/MS experiments (A) Workflow of LC-MS/MS experiments to detect RhoA-CL16 engagement in HCT116 cells. CL16-treated cells were harvested, digested and analyzed by LC-MS/MS. (B) Representative MS/MS showing CL16 modification on RhoA Cys16 in HCT116 cells. (C) Workflow of LC-MS/MS experiments using CL16-alkyne (a CL16-molecular probe) to study target profile of CL16. (D) Volcano plot revealing protein targets of CL16 identified by CL16-molecular probe. Statistical analyses were performed by two-tailed Student’s t-test by MS Excel. (E) Venn diagram summarizing the protein targets of CL16 identified in (A) and (C), highlighting RhoA as the primary target.

    Article Snippet: RhoA Pull-down Activation Assay Biochem Kit (bead pull-down format) , Cytoskeleton , Cat# BK036.

    Techniques: Biomarker Discovery, Binding Assay, Liquid Chromatography with Mass Spectroscopy, Tandem Mass Spectroscopy, Modification, Two Tailed Test

    Biochemical assays to Investigate RhoA inhibition by CL16 (A) Expected results of RhoGTPase activity assay in which CL16 selectively impairs the activation of RhoA and not Rac1 and Cdc42. (B) Schematic diagram illustrating the workflow of the co-immunoprecipitation experiment. (C) Expected results of co-immunoprecipitation whereas CL16 interferes with interactions between RhoA and ARHGEF1.

    Journal: STAR Protocols

    Article Title: Protocol to identify covalent inhibitors targeting RhoA Cys16

    doi: 10.1016/j.xpro.2026.104494

    Figure Lengend Snippet: Biochemical assays to Investigate RhoA inhibition by CL16 (A) Expected results of RhoGTPase activity assay in which CL16 selectively impairs the activation of RhoA and not Rac1 and Cdc42. (B) Schematic diagram illustrating the workflow of the co-immunoprecipitation experiment. (C) Expected results of co-immunoprecipitation whereas CL16 interferes with interactions between RhoA and ARHGEF1.

    Article Snippet: RhoA Pull-down Activation Assay Biochem Kit (bead pull-down format) , Cytoskeleton , Cat# BK036.

    Techniques: Inhibition, Activity Assay, Activation Assay, Immunoprecipitation